Pla2g2a attenuates colon tumorigenesis in azoxymethane-treated C57BL/6 mice; expression studies reveal Pla2g2a target genes and pathways

Cellular Oncology

Volumn 31, Issue 5, 2009, Pages 345-356

  Fijneman, Remond J A ^a   Bade, Lindsey K ^b   Peham, Johannes R ^a   Van De Wiel, Mark A ^a,c   Van Hinsbergh, Victor W M ^a   Meijer, Gerrit A ^a   O'Sullivan, Michael G ^d   Cormier, Robert T ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Colorectal cancer; Microarray expression analysis; Pla2g2a; Transgenic mice

Indexed keywords

AZOXYMETHANE; BETA CATENIN; PHOSPHOLIPASE A2 GROUP II; WNT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INCIDENCE; CELL CYCLE; COLON CARCINOGENESIS; DNA REPAIR; ENERGY METABOLISM; FEMALE; GENE CLUSTER; GENE EXPRESSION; GENE IDENTIFICATION; HISTOPATHOLOGY; LIPID METABOLISM; MALE; MICROARRAY ANALYSIS; MICROENVIRONMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; AZOXYMETHANE; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GROUP II PHOSPHOLIPASES A2; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC;

EID: 70149105950     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: 10.3233/CLO-2009-0480     Document Type: Article

References (73)

1. [1] T. Adachi, C.H. Cui, A. Kanda et al., Activation of epidermal growth factor receptor via CCR3 in bronchial epithelial cells, Biochem. Biophys. Res. Commun. 320 (2004), 292-296. (Pubitemid 38798864)
2. L. Adam, A. Mazumdar, T. Sharma et al., A three-dimensional and temporo-spatial model to study invasiveness of cancer cells by heregulin and prostaglandin E2, Cancer Res. 61 (2001), 81-87.
3. A. Aggarwal, D.L. Guo, Y. Hoshida et al., Topological and functional discovery in a gene coexpression meta-network of gastric cancer, Cancer Res. 66 (2006), 232-241.
4. W. Aizu, G.S. Belinsky, C. Flynn et al., Circumvention and reactivation of the p53 oncogene checkpoint in mouse colon tumors, Biochem. Pharmacol. 72 (2006), 981-991.
5. S. Angers, C.J. Thorpe, T.L. Biechele et al., The KLHL12Cullin-3 ubiquitin ligase negatively regulates the Wnt-betacatenin pathway by targeting Dishevelled for degradation, Nat. Cell Biol. 8(2006), 348-357.
6. D. Atanackovic, Y. Cao, J.W. Kim et al., The local cytokine and chemokine milieu within malignant effusions, Tumour Biol. 29 (2008), 93-104.
7. E. Batlle, J. Bacáni, H. Begthel et al., EphB receptor activity suppresses colorectal cancer progression, Nature 435 (2005), 1126-1130.
8. E. Batlle, J.T. Henderson, H. Beghtel et al., Beta-catenin and TCF mediate cell positioning in the intestinal epithelium, by controlling the expression of EphB/ephrinB, Cell 111 (2002), 251-263.
9. Y. Benjamini and Y. Hochberg, Controlling the false discovery rate: a practical and powerful approach to multiple testing, J. Roy. Stat. Soc. B 57 (1995), 289-300.
10. [10] L. Bennett, A.K. Palucka, E. Arce et al., Interferon and granulopoiesis signatures in systemic lupus erythematosus blood, J. Exp. Med. 197 (2003), 711-723. (Pubitemid 36350866)
11. A. Bissahoyo, R.S. Pearsall, K. Hanlon et al., Azoxymethane is a genetic background-dependent colorectal tumor initiator and promoter in mice: effects of dose, route, and diet, Toxicol. Sci. 88 (2005), 340-345.
12. [12] G.P. Boivin, K. Washington, K. Yang et al., Pathology of mouse models of intestinal cancer: consensus report and recommendations, Gastroenterology 124 (2003), 762-777. (Pubitemid 36268493)
13. E.P. Browne, B. Wing, D. Coleman et al., Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs, J. Virol. 75 (2001), 12319-12330.
14. B. Carvalho, C. Postma, S. Mongera et al., Multiple putative oncogenes at the chromosome 20q amplieon contribute to colorectal adenoma to carcinoma progression, Gut 58 (2009), 79-89.
15. [15] H. Clevers and E. Batlle, EphB/EphrinB receptors and Wnt signaling in colorectal cancer, Cancer Res. 66 (2006), 2-5. (Pubitemid 43165998)
16. R.T. Cormier, A. Bilger, A.J. Lillich et al., The Mom1AKR intestinal tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64, Oncogene 19 (2000), 3182-3192.
17. R.T. Cormier, K.H. Hong, R.B. Halberg et al., Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis, Nat. Genet. 17 (1997), 88-91.
18. P.A. Croonquist, M.A. Linden, R Zhao et al., Gene profiling of a myeloma cell line reveals similarities and unique signatures among IL-6 response, N-ras-activating mutations, and coculture with bone marrow stromal cells, Blood 102 (2003), 2581-2592.
19. [19] P. Demant, Cancer susceptibility in the mouse: genetics, biology and implications for human cancer, Nat. Rev. Genet. 4 (2003), 721-734. (Pubitemid 37046139)
20. S.D. Der, A. Zhou, B.R. Williams et al., Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays, Pmc. Natl. Acad Sci. USA 95 (1998), 15623-15628.
21. [21] W.R Dietrich, E.S. Lander, J.S. Smith et al., Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse, Cell 75 (1993), 631-639. (Pubitemid 23346362)
22. A. Fichera, N. Little, S. Jagadeeswaran et al., Epidermal growth factor receptor signaling is required for microadenoma formation in the mouse azoxymethane model of colonic carcinogenesis, Cancer Res. 67 (2007), 827-835.
23. R.J. Fijneman and R.T. Cormier, The roles of sPLA2-IIA (Pla2g2a) in cancer of the small and large intestine, Front. Biosci. 13 (2008), 4144-4174.
24. R.J. Fijneman and P. Demant, A gene for susceptibility to small intestinal cancer, ssic1, maps to the distal part of mouse chromosome 4, Cancer Res. 55 (1995), 3179-3182.
25. R.J. Fijneman, J.R. Peham, M.A. van de Wiel et al., Expression of Pla2g2a prevents carcinogenesis in Muc2-deficient mice, Cancer Sci. 99 (2008), 2113-2119.
26. K. Ganesan, T. Ivanova, Y. Wu et al., Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel betacatenin/TCF target gene, Cancer Res. 68 (2008), 4277-4286.
27. CM. Gao, T. Takezaki, J.Z. Wu et al., Polymorphisms of alcohol dehydrogenase 2 and aldehyde dehydrogenase 2 and colorectal cancer risk in. Chinese males, World J. Gastroenteml. 14 (2008), 5078-5083.
28. R.C. Gentleman, V.J. Carey, D.M. Bates et al., Bioconductor: open software development for computational biology and bioinformatics, Genome Biol. 5 (2004), R80.
29. A.W. Goldrath, C.J. Luckey, R. Park et al., The molecular program, induced in T cells undergoing homeostatic proliferation, Proc. Natl. Acad. Sci. USA 101 (2004), 16885-16890.
30. K.A. Gould, C. Luongo, A.R. Moser et al., Genetic evaluation of candidate genes for the Moml modifier of intestinal neoplasia in mice, Genetics 144 (1996), 1777-1785.
31. D. Greetham, CD. Ellis, D. Mewar et al., Functional characterization of NF-kappaB inhibitor-like protein. 1 (NFkappaBILl), a candidate susceptibility gene for rheumatoid arthritis, Hum. Mol. Genet. 16 (2007), 3027-3036.
32. K. Guda, K.P. Claffey, M. Dong et al., Defective processing of the transforming growth factor-betal in azoxymethane-induced mouse colon tumors, Mol. Caivinog. 37 (2003), 51-59.
33. K. Guda, H. Cui, S. Garg et al., Multistage gene expression profiling in a differentially susceptible mouse colon cancer model, Cancer Lett. 191 (2003), 17-25.
34. T. Hanada, T. Kobayashi, T. Chinen et al., IFNgammadependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice, J. Exp. Med. 203 (2006), 1391-1397.
35. D. Hartl, S. Krauss-Etschmann, B. Koller et al., Infiltrated neutrophils acquire novel chemokine receptor expression and chemokine responsiveness in chronic inflammatory lung diseases, J. Immunol. 181 (2008), 8053-8067.
36. K. Hata, Y. Yamada, T. Kuno et al., Tumor formation is correlated with expression of beta-catenin-accumulated crypts in azoxymethane-induced colon carcinogenesis in mice, Cancer Sci. 95(2004), 316-320.
37. T. Hinoi, M. Loda and E.R. Fearon, Silencing of CDX2 expression in colon cancer via a dominant repression pathway, J. Biol. Chem. 278 (2003), 44608-44616.
38. S. Holmes, A.M. Downs, A. Fosberry et al., Sema7A is a potent monocyte stimulator, Scand. J. Immunol. 56 (2002), 270-275.
39. K. Ishiguro, T. Ando, O. Maeda et al., Paeonol attenuates TNBS-induced colitis by inhibiting NF-kappaB and STAT1 transactivation, Toxicol. Appl. Pharmacol. 217 (2006), 35-42.
40. [40] M. Jechlinger, S. Grunert, I.H. Tamir et al., Expression profiling of epithelial plasticity in tumor progression, Oncogene 22 (2003), 7155-7169. (Pubitemid 37378548)
41. Y. Katoh and M. Katoh, Hedgehog signaling, epithelial-tomesenchymal transition and miRNA (review), Int. J. Mol. Med. 22 (2008), 271-275.
42. Y. Katoh and M. Katoh, Integrative genomic analyses on GLI2: mechanism of Hedgehog priming through basal GLI2 expression, and interaction map of stem cell signaling network with. P53, Int. J. Oncol, 33 (2008), 881-886.
43. E. Lapi, S. Di Agostino, S. Donzelli et al., PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop, Mol. Cell 32 (2008), 803-814.
44. S.Y. Leung, X. Chen, K.M. Chu et al., Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis, Proc. Natl. Acad. Sci. USA 99 (2002), 16203-16208.
45. D. Levy, N. Reuven and Y. Shaul, A regulatory circuit controlling Itch-mediated p73 degradation by Runx, J. Biol. Chem. 283 (2008), 27462-27468.
46. G. Liang, F.A. Gonzales, P.A. Jones et al., Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-aza-2'-deoxycytidine, Cancer Res. 62 (2002), 961-966.
47. M. Lindstedt, B. Johansson-Lindbom and CA. Borrebaeck, Global reprogramming of dendritic cells in response to a concerted action of inflammatory mediators, Int. Immunol, 14 (2002), 1203-1213.
48. M. MacPhee, K.P. Chepenik, R.A. Liddell et al., The secretory phospholipase A2 gene is a candidate for the Moml locus, a major modifier of ApcMin-induced intestinal neoplasia, Cell 81 (1995), 957-966.
49. L.W. Maines, L.R. Fitzpatrick, K.J. French et al., Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase, Dig. Dis. Sci. 53 (2008), 997-1012.
50. M. Markova, R.A. Koratkar, K.A. Silverman et al., Diversity in secreted PLA2-IIA activity among inbred mouse strains that are resistant or susceptible to Ape Min/+ tumorigenesis, Oncogene 24 (2005), 6450-6458.
51. K. Matsuo, N. Hamajima, T. Hirai et al., Aldehyde dehydrogenase 2 (ALDH2) genotype affects rectal cancer susceptibility due to alcohol consumption, J. Epidemiol. 12 (2002), 70-76.
52. A.G. McLennan, The Nudix hydrolase superfamily, Cell Mol. Life Sci. 63 (2006), 123-143.
53. [53] P. Minoo, I. Zlobec, K. Baker et al., Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancer, Mod. Pathol. 20 (2007), 331-338. (Pubitemid 46348330)
54. V.K. Mootha, C.M. Lindgren, K.R Eriksson et al., PGC1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nat. Genet. 34 (2003), 267-273.
55. H. Nagayoshi, A. Matsumoto, R. Nishi et al., Increased formation of gastric N(2)-ethylidene-2'-deoxyguanosine DNA adducts in aldehyde dehydrogenase-2 knockout mice treated with ethanol, Mutat. Res. 673 (2009), 74-77.
56. P.R. Nambiar, M. Nakanishi, R. Gupta et al., Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer, Cancer Res. 64 (2004), 6394-6401.
57. N.R Paoni, M.W. Feldman, L.S. Gutierrez et al., Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse, Physiol. Genomics 15 (2003), 228-235.
58. A. Papanikolaou, Q.S. Wang, D.A. Delker et al., Azoxymethane-induced colon tumors and aberrant crypt foci in. mice of different genetic susceptibility, Cancer Lett. 130 (1998), 29-34.
59. S. Radaeva, B. Jaruga, F. Hong et al., Interferon-alpha activates multiple STAT signals and down-regulates c-Met in primary human hepatocytes, Gastroenterology 122 (2002), 1020-1034.
60. R. Ramasawmy, K.C. Fae, E. Cunha-Neto et al., Variants in the promoter region of IKBL/NFKBIL1 gene may mark susceptibility to the development of chronic Chagas' cardiomyopathy among Trypanosoma cmzi-infected individuals, Mol. Immunol. 45 (2008), 283-288.
61. T.R. Sana, M.J. Janatpour, M. Sathe et al., Microarray analysis of primary endothelial cells challenged with different inflammatory and immune cytokines, Cytokine 29 (2005), 256-269.
62. O.J. Sansom, K.R. Reed, A.J. Hayes et al., Loss of Ape in vivo immediately perturbs Wnt signaling, differentiation, and migration, Genes Dev. 18 (2004), 1385-1390.
63. G.K. Smyth, Linear models and empirical Bayes methods for assessing differential expression in microarray experiments, Stat. Appl. Genet. Mol. Biol. 3 (2004), Article 3.
64. N.M. Sorensen, M. Kobaek-Larsen, A. Bonne et al., Analysis of beta-catenin, Ki-ras, and microsatellite stability in. azoxymethane-induced colon tumors of BDIX/Orl Ico rats, Comp. Med. 53 (2003), 633-638.
65. A. Subramanian, P. Tamayo, V.K. Mootha et al., Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles, Proc. Natl. Acad. Sci. USA 102 (2005), 15545-15550.
66. R. Suzuki, H. Kohno, S. Sugie et al., Strain differences in the susceptibility to azoxymethane and dextran sodium, sulfateinduced colon carcinogenesis in mice, Carcinogenesis 27 (2006), 162-169.
67. [67] M. Takahashi, S. Nakatsugi, T. Sugimura et al., Frequent mutations of the beta-catenin gene in mouse colon tumors induced by azoxymethane, Carcinogenesis 21 (2000), 1117-1120. (Pubitemid 30389335)
68. A. Takeda, C. Goolsby and N.R. Yaseen, NUP98-HOXA9 induces long-term, proliferation and blocks differentiation of primary human CD34+ hematopoietic cells, Cancer Res. 66 (2006), 6628-6637.
69. H. Yamaguchi, K. Bhalla and H.G. Wang, Bax plays a pivotal role in thapsigargin-induced apoptosis of human colon cancer HCT116 cells by controlling Smac/Diablo and Omi/HtrA2 release from mitochondria, Cancer Res. 63 (2003), 1483-1489.
70. Z. Yang, X. Zhang, H. Gang et al., Up-regulation of gastric cancer cell invasion by Twist is accompanied by N-cadherin and fibronectin expression, Biochem. Biophys. Res. Commun. 358 (2007), 925-930.
71. F. Zhan, Y. Huang, S. Colla et al., The molecular classification of multiple myeloma, Blood 108 (2006), 2020-2028.
72. H. Zhao, L.E. Wang, D. Li et al., Genotypes and haplotypes of ERCC1 and ERCC2/XPD genes predict levels of benzo[a]pyrene diol epoxide-induced DNA adducts in cultured primary lymphocytes from healthy individuals: a genotypephenotype correlation analysis, Carcinogenesis 29 (2008), 1560-1566.
73. H. Zhu, J.P. Cong, G. Mamtora et al., Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays, Proc. Natl. Acad. Sci. USA 95 (1998), 14470-14475.